CORBF Stock — Price, Charts & Analysis

Global Cord Blood Corporation (CORBF) has a trailing P/E of 3.39x. This places CORBF in a lower earnings multiple territory based on the valuation data currently available on Worldtickers.

CORBF trades with 3.39x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether CORBF looks overvalued or undervalued.

CORBF's P/E of 3.39x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

CORBF's trailing EPS is $0.31. Reported earnings growth is -18.20%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Global Cord Blood Corporation generated for each share. CORBF's trailing EPS is $0.31, and investors usually prefer EPS that is positive and growing over time.

Global Cord Blood Corporation has a market cap of $140.61M, making CORBF a small-cap stock based on the current market value shown on Worldtickers.

CORBF's latest stock price on Worldtickers is $1.05. The latest move is $0.00 or 0.00%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

CORBF's quote includes a latest price of $1.05. The market open is $0.75. Previous close is $1.05. The intraday range is $0.75 to $0.75.

CORBF is up in the latest quote, with a move of $0.00 or 0.00%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

CORBF generated $1.24B in trailing revenue. Revenue growth is -1.70%, which helps show whether demand is expanding or slowing.

CORBF's revenue growth is -1.70%, which is a negative demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, CORBF shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is $501.06M.

Gross margin is 85.26%. Margins show how efficiently Global Cord Blood Corporation turns revenue into profit.

Global Cord Blood Corporation carries $147.00K and holds $6.66B in cash.

CORBF holds $6.66B on its balance sheet.

CORBF's book value per share is $5.95.

Institutions hold 13.40% of CORBF shares. Insiders hold 0.00% of shares. Ownership mix helps investors understand how much of Global Cord Blood Corporation is held by professional investors and company insiders.

CORBF has 133.91M shares outstanding. Float shares are 116.52M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for CORBF, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Earnings growth is -18.20%. Revenue growth is -1.70%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

CORBF's trailing EPS is $0.31. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

CORBF is in the Healthcare sector. Its earnings multiple is 3.39x. Its latest displayed growth metric is -1.70%. Compare these figures with sector peers before deciding whether Global Cord Blood Corporation is stronger or weaker than average.

CORBF trades at $1.05. The stock trades at 3.39x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Global Cord Blood Corporation's fundamentals.

CORBF risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is -0.77, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

CORBF should be compared with companies in Diagnostics & Research. Its earnings multiple is 3.39x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Global Cord Blood Corporation (CORBF) operates in Healthcare, specifically Diagnostics & Research. Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a

CORBF trades on OTC Markets OTCPK. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

CORBF stock is priced in USD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Global Cord Blood Corporation employs about 1.2K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Global Cord Blood Corporation is headquartered in Central, Hong Kong. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

CORBF is in the Healthcare sector and the Diagnostics & Research industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

CORBF has traded between $0.20 and $1.75 over the past 52 weeks. At $1.05, it is 40.00% below the high and 425.00% above the low. The 52-week range helps gauge long-term price momentum.

CORBF is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is $0.95 and its 200-day moving average is $0.95.

CORBF's RSI is 44.39. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

CORBF's latest RSI reading is 44.39, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for CORBF is near $0.95. Key resistance is near $0.95. Breaks above resistance or below support can change the short-term technical setup.

CORBF's nearest reported support level is $0.95. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

CORBF's nearest reported resistance level is $0.95. A breakout above resistance can improve momentum, especially when volume confirms the move.

CORBF trades about 6.21K shares daily on average. The latest displayed volume is 600 shares. Volume helps show liquidity and whether trading interest is unusually high or low.

CORBF's MACD is 0.00, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

CORBF is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 44.39 (neutral). MACD is bullish. Nearest support is around $0.95. Resistance is around $0.95. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is $0.95 (0.00% from price). MA50 is $0.95 (-0.31% from price). MA200 is $0.95 (-0.05% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. CORBF's MA20 is $0.95. MA50 is $0.95. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

CORBF's pivot is near $0.95. Support is near $0.95. Resistance is near $0.95. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

CORBF's Bollinger range is roughly $0.95 to $0.95. Band width is near 0.00%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

CORBF's ATR-based typical daily range is about 0.07%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 600 shares. Average volume is about 6.21K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

CORBF's all-time high shown on Worldtickers is $14.95. Its all-time low is $0.02. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

CORBF has a beta of -0.77, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.